| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $207.7M | — | +38.6% |
| Cost of Revenue | $23.4M | — | +48.4% |
| R&D Expense | $39.4M | — | +46.5% |
| SG&A Expense | $125.2M | — | +39.2% |
| Operating Income | -$8.3M | — | +18.8% |
| Pre-tax Income | -$6.0M | — | -2.0% |
| Income Tax | -$3.7M | — | -161.0% |
| Net Income | -$2.3M | — | +80.6% |
| EPS (Basic) | -$0.04 | — | +81.0% |
| EPS (Diluted) | -$0.04 | — | +81.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $184.9M | +43.9% | +59.6% |
| Accounts Receivable | $182.2M | -3.0% | +25.1% |
| Inventory | $110.8M | -1.5% | +124.1% |
| Current Assets | $731.6M | +13.6% | +6.4% |
| Total Assets | $1.50B | +3.3% | +11.4% |
| Current Liabilities | $373.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $66.5M | — | +117.4% |
| Capital Expenditures | $0 | — | -100.0% |
| Investing Cash Flow | -$19.2M | — | -151.5% |
| Financing Cash Flow | $9.1M | — | +142.6% |
| Free Cash Flow | $66.5M | — | +119.8% |
| +32.7% |
| Total Liabilities | $423.9M | +8.4% | +33.9% |
| Stockholders' Equity | $1.08B | +1.4% | +4.5% |